Endotoxin detection and removal using Hyglos products!


is a biotech company located in Biotechnology Center Bernried, Munich area, Germany. develops and produces highly specific bacteriophage recombinant proteins for binding and destroying harmful bacteria and bacterial toxins such as Lipopolysaccharides (LPS).

The product portfolio includes the EndoLISA® Endotoxin Test, which was the world's first solid-phase based assay for endotoxin detection and overcomes limitations of existing methods, such as the need for substantial dilution. EndoLISA® is based on a lipopolysaccharide (LPS) specific phage recombinant protein, which specifically binds to the entire substance group of LPS (endotoxin). The phage protein is pre-coated to the wells in the EndoLISA® microtiter plate and as the sample is added to the well, the endotoxin (LPS) in the sample is bound to the phage protein.

also offers the EndoZyme® Endotoxin Test which is intended for in vitro quantitative determination of endotoxin (lipopolysaccharide, LPS) in pharmaceuticals and biological substances as well as for medical device testing. EndoZyme® is best suited for non-complex samples and buffer conditions.